[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343076-105":59,"doc-detail-343076-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","advances-in-breast-cancer-treatment-a-systematic-review-of-preoperative-stereotactic-body-radiotherapy-sbrt-for-breast-cancer","Advances in breast cancer treatment - a systematic review of preoperative stereotactic body radiotherapy (SBRT) for breast cancer","","Breast conserving treatment often requires surgical excision plus adjuvant radiotherapy, but accurately defining the tumor bed is difficult, risking irradiation of larger volumes of healthy tissue. This systematic literature review evaluates preoperative stereotactic body radiotherapy (SBRT) by analyzing early toxicity and cosmetic outcomes, and additionally reviews pathological complete response (pCR) rates, late toxicity, patient selection criteria, and protocols. Ten prospective trials (188 patients) were included, with follow-up around 15 months.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/advances-in-breast-cancer-treatment-a-systematic-review-of-preoperative-stereotactic-body-radiotherapy-sbrt-for-breast-cancer/343076/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/advances-in-breast-cancer-treatment-a-systematic-review-of-preoperative-stereotactic-body-radiotherapy-sbrt-for-breast-cancer/343076.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does preoperative SBRT aim to solve in breast-conserving treatment?","Question",{"text":112,"@type":113},"It targets the tumor itself rather than the tumor bed, helping avoid irradiation of greater volumes of healthy tissues caused by challenges in tumor bed definition.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which outcomes does the systematic review focus on?",{"text":117,"@type":113},"It assesses early toxicity and cosmetic outcomes, and also reviews pathological complete response (pCR) rates, late toxicity, patient selection criteria, and radiotherapy protocols.",{"name":119,"@type":110,"acceptedAnswer":120},"What do early results suggest about cosmetic effects and toxicity?",{"text":121,"@type":113},"Cosmetic outcomes were excellent in 85–100% of patients and toxicity G2 ranged roughly 0–17% (acute) and 0–19% (late), with rare G3 toxicity, indicating low toxicity and strong cosmetic performance.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343076,1790190754,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Bilski et al. Radiation Oncology (2024) 19:103 [https://doi.org/10.1186/s13014-024-02497-4](https://doi.org/10.1186/s13014-024-02497-4)  \nRadiation Oncology  \n REVIEW Open Access  \nAdvances in breast cancer treatment:  \na systematic review of preoperative stereotactic body radiotherapy (SBRT) for breast cancer  \nMateusz Bilski1,2,3, Katarzyna Konat-Bąska4, Maria Alessia Zerella5, Stefanie Corradini6,  \nMarcin Hetnał7,8, Maria Cristina Leonardi5, Martyna Gruba1, Aleksandra Grzywacz1, Patrycja Hatala 1, Barbara Alicja Jereczek-Fossa5,9, Jacek Fijuth10,11 and Łukasz Kuncman10,11*  \nAbstract  \nBreast conserving treatment typically involves surgical excision of tumor and adjuvant radiotherapy targeting the breast area or tumor bed. Accurately defining the tumor bed is challenging and lead to irradiation of greater volume of healthy tissues. Preoperative stereotactic body radiotherapy (SBRT) which target tumor may solves that issues. We conducted a systematic literature review to evaluates the early toxicity and cosmetic outcomes ofthis promising treatment approach. Secondary we reviewed pathological complete response (pCR) rates, late toxicity, patient selection criteria and radiotherapy protocols. We retrieved literature from PubMed, Scopus, Web of Science, Cochrane, ScienceDirect, [and ClinicalTrials.gov. The](and ClinicalTrials.gov. The) study adhered to the PRISMA 2020 guidelines. Ten prospective clinical trials (7 phase II, 3 phase I), encompassing 188 patients (aged 18–75 years, cT1-T3 cN0-N3 cM0, primarily with ER/PgR-positive, HER2-negative status,), were analyzed. Median follow-up was 15 months (range 3–30) . Treatment involved singlefraction SBRT (15-21Gy) in five studies and fractionated (19 .5–31. 5Gy in 3 fractions) in the rest. Time interval from SBRT to surgery was 9.5 weeks (range 1–28) . Acute and late G2 toxicity occurred in 0–17% and 0–19% of patients, respectively, G3 toxicity was rarely observed. The cosmetic outcome was excellent in 85–100%, fair in 0–10% and poor in only 1 patient. pCR varied, showing higher rates (up to 42%) with longer intervals between SBRT and surgery and when combined with neoadjuvant systemic therapy (up to 90%) . Preoperative SBRT significantly reduce overall treatment time, enabling to minimalize volumes. Early results indicate excellent cosmetic effects and low toxicity. Keywords Breast cancer, Breast neoplasm, Breast tumor, Stereotactic ablative body radiotherapy, Stereotactic body radiation therapy, SBRT, SABR, Preoperative, Neoadjuvant, Tumor bed  \n*Correspondence:  \nŁukasz Kuncman  \n[lukasz.kuncman@umed.lodz.pl](lukasz.kuncman@umed.lodz.pl)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nBilski et al. Radiation Oncology (2024) 19:103 Page 2 of 22  \n\n| Graphical abstract\u003Cbr>PREOPERATIVE RADIOTHERAPY FOR BREAST CANCER\u003Cbr>S","cbCaie41hHRT49Mv","https://ap.wps.com/l/cbCaie41hHRT49Mv","pdf",1231536,22,"English","# Abstract\n# Background\n# Introduction","[{\"question\":\"What problem does preoperative SBRT aim to solve in breast-conserving treatment?\",\"answer\":\"It targets the tumor itself rather than the tumor bed, helping avoid irradiation of greater volumes of healthy tissues caused by challenges in tumor bed definition.\"},{\"question\":\"Which outcomes does the systematic review focus on?\",\"answer\":\"It assesses early toxicity and cosmetic outcomes, and also reviews pathological complete response (pCR) rates, late toxicity, patient selection criteria, and radiotherapy protocols.\"},{\"question\":\"What do early results suggest about cosmetic effects and toxicity?\",\"answer\":\"Cosmetic outcomes were excellent in 85–100% of patients and toxicity G2 ranged roughly 0–17% (acute) and 0–19% (late), with rare G3 toxicity, indicating low toxicity and strong cosmetic performance.\"}]","Advances in breast cancer treatment - a systematic review of preoperative stereotactic body radiotherapy (SBRT) for breast cancer | PDF",1790049775,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/76e5147dab2410177d6d95d59fcc79c3.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c6e770736847fd1a598219c4f3c7a98.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d247f715cc7c28e3aeb5353e1d08bdc.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/419871098647b3214ca5ed722e12b2b6.webp",980,1301]